Trade Agreement: Canadian Free Trade Agreement (CFTA)
Tendering Procedures: All interested suppliers may submit a bid
Competitive Procurement Strategy: Lowest/Lower Bid
Comprehensive Land Claim Agreement: No
Nature of Requirements:
PERTUSSIS VACCINES
E60PH-21PERT/A
Baird, Christa
Telephone No. - (403) 991-5231
Description:
Federal, Provincial and Territorial (F/P/T) jurisdictions have a requirement for the supply and delivery of pediatric Pertussis-containing vaccines as part of the F/PT Group Purchasing Program.
Term of Contract:
Resulting contracts will be from the April 1, 2021 to March 31, 2025 with one additional one-year option period.
Up to two (2) contracts will be awarded for each of the following vaccines.
Vaccines and Quantity:
DTaP-IPV-Hib Vaccine (Diphtheria, Tetanus, acellular Pertussis, Polio and Infant Haemophilus type B Vaccine) maximum estimated quantity of 5,941,833
Hib Vaccine (Haemophilus influenza type b), maximum estimated quantity of 187,660
Tdap Vaccine (Combined diphtheria, tetanus, acellular pertussis), maximum estimated quantity of 9,244,605
Tdap-IPV (Combined diphtheria, tetanus, acellular pertussis (adsorbed) and inactivated poliomyelitis), maximum estimated quantity of 3,515,393
Basis of Selection:
For each vaccine: A bid must comply with the requirements of the bid solicitation and meet all mandatory evaluation criteria to be declared responsive. The responsive bids with the two lowest evaluated prices will be recommended for award as set out in solicitation.
Delivery:
As and when requested.
This requirement is for the Federal/Provincial/Territorial(F/P/T) Group Purchasing Program for Drugs and Vaccines. Canada is acting as a purchasing agent for Provincial and Territorial Governments.
Delivery Date: 01/04/2021
The Crown retains the right to negotiate with suppliers on any procurement.
Documents may be submitted in either official language of Canada.
